• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Tris Pharma - Articles and news items


Twice-daily cough syrup Tuzistra XR launched in the US

Industry news / 8 September 2015 / Victoria White

Tuzistra XR is the only codeine-based extended-release cough cold syrup available to patients and physicians in the United States…


FDA accepts for review New Drug Application for Dyanavel XR in ADHD

Industry news / 22 May 2015 / Victoria White

Tris Pharma has announced that the FDA has accepted for review its New Drug Application for Dyanavel XR, an Extended-Release Oral Suspension…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +